Presentations Stuart Ashman Discusses Winclove – AxisBiotix® Agreement 5th May 2020 9:57 am6th May 2020 Previous ArticleStuart Ashman CEO at AJ Bell Investor EveningNext ArticleStuart Ashman Discusses Croda PLC – SkinBiotix® Agreement